We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

117 hedge funds and large institutions have $349M invested in Aldeyra Therapeutics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 45 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

773% more call options, than puts

Call options by funds: $19.1M | Put options by funds: $2.18M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

9.9% less ownership

Funds ownership: 78.59% → 68.69% (-9.9%)

14% less funds holding

Funds holding: 136 → 117 (-19)

32% less capital invested

Capital invested by funds: $511M → $349M (-$162M)

33% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 45

53% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 34

Holders
117
Holders Change
-19
Holders Change %
-13.97%
% of All Funds
2.05%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
30
Reduced
45
Closed
34
Calls
$19.1M
Puts
$2.18M
Net Calls
+$16.9M
Net Calls Change
+$14.4M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$3.62M
2
HP
HealthInvest Partners
Sweden
+$2.85M
3
State Street
State Street
Massachusetts
+$2.7M
4
EAM
Eagle Asset Management
Florida
+$2.39M
5
CM
Caption Management
Oklahoma
+$1.63M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$16.4M
2
TLP
Tri Locum Partners
New York
-$9.27M
3
Goldman Sachs
Goldman Sachs
New York
-$8.13M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$5.22M
5
AG
Artal Group
Luxembourg
-$4.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.61M -$351K -38,192 -17%
CM
27
Caption Management
Oklahoma
$1.56M +$1.63M +177,279 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$1.5M +$502K +54,655 +47%
PAI
29
Palo Alto Investors
California
$1.41M – – –
WC
30
Woodstock Corp
Massachusetts
$1.3M – – –
WMSA
31
Weiss Multi-Strategy Advisers
New York
$1.29M +$60K +6,535 +5%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$1.27M +$105K +11,400 +9%
CS
33
Candriam SCA
Luxembourg
$1.23M – – –
UBS Group
34
UBS Group
Switzerland
$1.21M +$1.12M +122,307 +822%
Charles Schwab
35
Charles Schwab
California
$1.09M -$3.79K -413 -0.3%
Goldman Sachs
36
Goldman Sachs
New York
$1.07M -$8.13M -885,564 -88%
JC
37
Jetstream Capital
Tennessee
$966K +$1.01M +110,000 New
GCP
38
GSA Capital Partners
United Kingdom
$907K +$738K +80,407 +352%
Citigroup
39
Citigroup
New York
$835K -$1.07M -116,650 -55%
Bank of America
40
Bank of America
North Carolina
$818K -$47.8K -5,211 -5%
Group One Trading
41
Group One Trading
Illinois
$714K +$746K +81,321 New
AA
42
ALPS Advisors
Colorado
$623K -$45.8K -4,988 -7%
Assenagon Asset Management
43
Assenagon Asset Management
Luxembourg
$608K -$5.22M -569,094 -89%
Stifel Financial
44
Stifel Financial
Missouri
$604K +$119K +12,991 +23%
CAM
45
ClariVest Asset Management
California
$590K -$5.51K -600 -0.9%
DCM
46
Dupont Capital Management
Delaware
$560K +$585K +63,786 New
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$551K – – –
AC
48
Apogem Capital
New York
$497K +$100K +10,922 +24%
Morgan Stanley
49
Morgan Stanley
New York
$483K -$336K -36,627 -40%
Jane Street
50
Jane Street
New York
$469K +$369K +40,240 +304%
1
2
3 4 5

ALDX Hedge Fund Activity: Q3 2021 in Review

117 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2021, worth a combined $349M — down 32% from $511M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of ALDX and 16 opened new positions — a net loss of 18 holders — while 45 trimmed existing stakes and 30 added.

The largest buyer was Woodline Partners, adding an estimated $3.62M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $16.4M sold.

  • 117 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2021, down from 136 in Q2 2021.
  • Funds reported $349M of Aldeyra Therapeutics stock for Q3 2021, down 32% quarter-over-quarter.
  • 16 funds opened new Aldeyra Therapeutics positions in Q3 2021 and 34 closed out, a net change of -18 holders.
  • The largest Aldeyra Therapeutics buyer in Q3 2021 was Woodline Partners, an estimated $3.62M added.
  • The largest Aldeyra Therapeutics seller in Q3 2021 was Avidity Partners Management, an estimated $16.4M sold.

Based on aggregated 13F filings for Q3 2021.